CLINICAL_TRIALS
trial_result
· 2017-11-09
Clinical Trial Update: A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids (MK-0822-066) [Phase 1]
Summary
Phase 1 trial evaluating odanacatib (MK-0822) in adolescents and young adults treated with glucocorticoids for osteoporosis has been terminated; results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 1 | Status: TERMINATED | Results posted: 2017-11-09